Dysfunctional efferocytosis impairs clearance of apoptotic cells in disease. A new study shows that glutamine catabolism supports efficient apoptotic cell efferocytosis via non-canonical glutamine transamination but not canonical GLUD1-dependent α-ketoglutarate production, in a process that may operate in human atherosclerosis.
This is a preview of subscription content, log in via an institution to check access.
References
Merlin, J. et al. Nat. Metab. https://doi.org/10.1038/s42255-021-00471-y (2021).
Morioka, S. et al. Nature 539, 714–718 (2019).
Zhang, S. et al. Cell Metab. 29, 443–456.e5 (2019).
Park, D. et al. Nature 477, 220–224 (2011).
Yurdagul, A. Jr et al. Cell Metab. 31, 518–533.e10 (2020).
Jha, A. K. et al. Immunity 42, 419–430 (2015).
Liu, P. S. et al. Nat. Immunol. 18, 985–994 (2017).
Viràg, L. et al. Redox Biol. 26, 2213–2317 (2019).
Werfel, T. & Cook, R. S. Semin. Immunopathol. 40, 545–554 (2018).
Oh, M. H. et al. J. Clin. Investig. 130, 3865–3884 (2020).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Jaccard, A., Li, X. & Ho, PC. Glutamine gluttony of efferocytes. Nat Metab 3, 1280–1281 (2021). https://doi.org/10.1038/s42255-021-00462-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-021-00462-z
- Springer Nature Limited